19.01.2018 • News

Hexion Sells Additives Technology to Münzing

German specialty additive company Münzing Chemie takes over US resins producer...
German specialty additive company Münzing Chemie takes over US resins producer Hexion's additives technology group (ATG). © Münzing Chemie

US resins producer Hexion (formerly Momentive Specialty Chemicals) has sold its additives technology group (ATG) to German specialty additive company Münzing Chemie for approximately $50 million. The business operated within Hexion’s forest products resins segment.

The sale includes manufacturing sites in Somersby, Australia, and Sungai Petani, Malaysia, along with certain intangible property. The sites produce specialty chemical materials for the engineered wood, paper impregnation and laminating industries, including catalysts, release agents and wetting agents.

 “We are pleased to successfully complete the sale of our ATG business,” said Hexion CEO Craig Rogerson. “We continue to position the company for profitable growth by strategically managing our portfolio and optimizing our cost structure.”

Hexion said it will use the proceeds for general corporate purposes. The Columbus, Ohio-headquartered company is controlled by investment funds affiliated with US private equity group Apollo Global Management.

Privately owned, Münzing has its headquarters in Abstatt and manufacturing plants in Elsteraue and Heilbronn, Germany; Clover, South Carolina, USA; and Taixing, China, which offer broad synthesis and formulation capabilities.

 

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.